Koers NeoGenomics, Inc. OTC Bulletin Board
Aandelen
US64049M2098
Gezondheidszorgvoorzieningen & -diensten
slotkoers
Andere beurzen
|
||
- USD | - |
|
28/05 | NeoGenomics, Inc. introduceert uitgebreide longoplossing & biedt hematopathologische diensten aan op ASCO | CI |
30/04 | NEOGENOMICS, INC. : Needham & Co. geeft koopadvies | ZM |
Omzet 2024 * | 656 mln. 606 mln. | Omzet 2025 * | 719 mln. 664 mln. | Marktkapitalisatie | 1,75 mld. 1,62 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -72 mln. -66,5 mln. | Nettowinst (verlies) 2025 * | -47 mln. -43,41 mln. | EV/omzet 2024 * | 3,08 x |
Nettoschuld 2024 * | 265 mln. 245 mln. | Nettoschuld 2025 * | 238 mln. 220 mln. | EV/omzet 2025 * | 2,77 x |
K/w-verhouding 2024 * |
-24,1
x | K/w-verhouding 2025 * |
-38
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,75% |
Recentste transcriptie over NeoGenomics, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chris Smith
CEO | Chief Executive Officer | 61 | 15-08-22 |
Lynn Tetrault
CHM | Chairman | 61 | 12-06-15 |
Jeffrey Sherman
DFI | Director of Finance/CFO | 58 | 07-12-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Kelly
BRD | Director/Board Member | 67 | 15-07-20 |
Chris Smith
CEO | Chief Executive Officer | 61 | 15-08-22 |
David Perez
BRD | Director/Board Member | 63 | 03-11-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-18,64% | 8,32 mld. | |
+70,43% | 4,38 mld. | |
+12,00% | 2,9 mld. | |
-2,10% | 2,65 mld. | |
-58,41% | 1,66 mld. | |
-16,63% | 1,49 mld. | |
+24,33% | 1,28 mld. | |
-50,73% | 999 mln. | |
+17,26% | 967 mln. |